PT710689E - Novos agentes polimericos antitumorais - Google Patents

Novos agentes polimericos antitumorais

Info

Publication number
PT710689E
PT710689E PT95307637T PT95307637T PT710689E PT 710689 E PT710689 E PT 710689E PT 95307637 T PT95307637 T PT 95307637T PT 95307637 T PT95307637 T PT 95307637T PT 710689 E PT710689 E PT 710689E
Authority
PT
Portugal
Prior art keywords
antitumor agents
new polymeric
polymeric antitumor
agents
new
Prior art date
Application number
PT95307637T
Other languages
English (en)
Inventor
Hwei-Ru Tsou
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PT710689E publication Critical patent/PT710689E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/028—Polyamidoamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/595—Polyamides, e.g. nylon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0273—Polyamines containing heterocyclic moieties in the main chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polyamides (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
PT95307637T 1994-11-01 1995-10-26 Novos agentes polimericos antitumorais PT710689E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33266194A 1994-11-01 1994-11-01
US08/521,505 US5609867A (en) 1994-11-01 1995-08-29 Polymeric antitumor agents

Publications (1)

Publication Number Publication Date
PT710689E true PT710689E (pt) 2003-08-29

Family

ID=26988319

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95307637T PT710689E (pt) 1994-11-01 1995-10-26 Novos agentes polimericos antitumorais

Country Status (11)

Country Link
US (1) US5609867A (pt)
EP (1) EP0710689B1 (pt)
JP (1) JPH08253420A (pt)
AT (1) ATE239047T1 (pt)
AU (1) AU690740B2 (pt)
CA (1) CA2161603A1 (pt)
DE (1) DE69530552T2 (pt)
DK (1) DK0710689T3 (pt)
ES (1) ES2197183T3 (pt)
PT (1) PT710689E (pt)
TW (1) TW383318B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2243649C (en) * 1996-02-15 2009-08-04 J. Paul Santerre Bioresponsive pharmacologically-active polymers and articles made therefrom
AU2014293011A1 (en) 2013-07-26 2016-03-17 Race Oncology Ltd. Compositions to improve the therapeutic benefit of bisantrene

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714993A (en) 1970-11-23 1973-02-06 Hughes Tool Co Valving tube subassembly for percussion bit
US4197249A (en) 1977-08-15 1980-04-08 American Cyanamid Company 1,4-Bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
US4526788A (en) * 1983-03-18 1985-07-02 American Cyanamid Company Polymeric[[(oxazolidinyl)alkyl]amino]anthraquinones
US4520162A (en) * 1983-09-24 1985-05-28 Director-General Of The Agency Of Industrial Science & Technology Polymeric compounds with sustained anti-tumor activity and a method for the preparation thereof
GB8413464D0 (en) 1984-05-25 1984-07-04 Erba Farmitalia Anthracycline-anionic polymer conjugates
DE3768419D1 (de) * 1986-10-07 1991-04-11 Boehringer Biochemia Srl Pharmazeutische zusammensetzungen mit antineoplastischer wirkung.
US5378456A (en) * 1993-03-25 1995-01-03 American Cyanamid Company Antitumor mitoxantrone polymeric compositions

Also Published As

Publication number Publication date
EP0710689A3 (en) 1996-11-20
AU690740B2 (en) 1998-04-30
DE69530552T2 (de) 2003-11-20
AU3454795A (en) 1996-05-09
EP0710689B1 (en) 2003-05-02
ES2197183T3 (es) 2004-01-01
JPH08253420A (ja) 1996-10-01
DK0710689T3 (da) 2003-08-04
US5609867A (en) 1997-03-11
EP0710689A2 (en) 1996-05-08
DE69530552D1 (de) 2003-06-05
ATE239047T1 (de) 2003-05-15
TW383318B (en) 2000-03-01
CA2161603A1 (en) 1996-05-02

Similar Documents

Publication Publication Date Title
MY126559A (en) Fungicidal 2-methoxybenzophenones
SG77195A1 (en) Fungicidal 2-methoxybenzophenones
TW269678B (pt)
DE69319976T2 (de) 7-Substituierte-9-substituierte Glycylamido-6-Demethyl-6-Deoxytetracycline
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
DE3865817D1 (pt)
HU9402342D0 (en) Phosphono-oxymethyl-ethers of taxane derivatives
PT1130963E (pt) Combinacoes de substancias activas fungicidas
BG106390A (en) Novel spiro compounds
NZ225339A (en) Compounds having biocidal properties and pharmaceutical compositions
DK1385514T5 (da) Spiroinden- og spiroindanforbindelser
ES8704931A1 (es) Un procedimiento para la preparacion de derivados de piridimilmidazolidiona.
CA2152771A1 (en) 7-o-ethers of taxane derivatives
DE60013994D1 (de) 1,2-Disubstituierte 1,4-Dihydro-4-oxochinolin-Verbindungen
EP1073447A4 (en) N1-MODIFIED GLYCOPEPTIDES
PT710689E (pt) Novos agentes polimericos antitumorais
DK1011329T3 (da) 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler
IL161920A0 (en) Photochromic oxazine compounds and methods for their manufacture
ES2108165T3 (es) Compuestos policiclicos 31668p y 31668u, un procedimiento para su produccion y su uso como agentes antibioticos o antitumorales.
AP9200347A0 (en) Fungicides.
ATE261962T1 (de) Benzonaphtyridin-1,8 derivate
RU93045448A (ru) Этил-бис(1-алкил-3-бутоксикарбонилуреидо)-тиофосфаты, проявляющие фунгицидную активность